New products in the Russian market

This October, Xantis Pharma launched two new products in Russia; Telmisartan HCT and Telmisartan mono. Telmisartan HCT is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide, the most common diuretic to be combined with other blood pressure lowering substances.